Biotech Stocks

US-listed biological-products companies: therapies derived from biological processes, distinct from small-molecule pharmaceutical manufacturers.

71 companies

Companies

Combined revenue

$96.44B

Median net margin

6.8%

Median P/E

24.9×

Company	Revenue	Net margin	P/E	Market cap
Amgen Inc. (AMGN)	$36.75B	21.0%	26.9×	$233.82B
Gilead Sciences, Inc. (GILD)	$29.44B	28.9%	—	$193.67B
Biogen Inc. (BIIB)	$9.89B	13.1%	41.3×	$34.37B
Neurocrine Biosciences Inc. (NBIX)	$2.86B	16.7%	19.8×	$13.92B
Exelixis, Inc. (EXEL)	$2.32B	33.7%	18.8×	$15.11B
Qiagen N.V. (QGEN)	$2.09B	20.3%	23.0×	$9.37B
Moderna, Inc. (MRNA)	$1.94B	—	—	$87.04B
Halozyme Therapeutics, Inc. (HALO)	$1.40B	22.7%	35.6×	$13.83B
BIO-TECHNE Corp (TECH)	$1.22B	15.0%	62.5×	$11.36B
Novavax Inc. (NVAX)	$1.12B	39.2%	—	$1.86B
Biocryst Pharmaceuticals Inc. (BCRX)	$874.8M	30.2%	—	$2.06B
Repligen Corp. (RGEN)	$738.3M	6.6%	238.2×	$11.04B
Adma Biologics, Inc. (ADMA)	$510.2M	28.8%	14.7×	$2.40B
Tarsus Pharmaceuticals, Inc. (TARS)	$451.4M	-14.7%	—	$3.48B
Immunocore Holdings plc (IMCR)	$400.0M	-8.9%	—	$1.50B
Krystal Biotech, Inc. (KRYS)	$389.1M	52.6%	41.6×	$9.83B
Twist Bioscience Corp (TWST)	$376.6M	-20.6%	—	$10.07B
Adaptive Biotechnologies Corp (ADPT)	$277.0M	-21.5%	—	$3.83B
Vericel Corp (VCEL)	$276.3M	6.0%	85.6×	$2.06B
Iovance Biotherapeutics, Inc. (IOVA)	$263.5M	—	—	$6.60B
Vaxart, Inc. (VXRT)	$237.3M	6.9%	2.7×	$110.9M
Adaptimmune Therapeutics PLC (ADAPY)	$178.0M	-39.8%	—	$8.0M
REGENXBIO Inc. (RGNX)	$170.4M	—	—	$457.1M
Ginkgo Bioworks Holdings, Inc. (DNA)	$170.2M	—	—	$791.9M
Beam Therapeutics Inc. (BEAM)	$139.7M	-57.2%	—	$2.42B
Monte Rosa Therapeutics, Inc. (GLUE)	$123.7M	-31.2%	—	$863.4M
Atara Biotherapeutics, Inc. (ATRA)	$120.8M	27.1%	—	$96.0M
Agenus Inc. (AGEN)	$114.2M	-2.7%	—	$313.9M
ImmunityBio, Inc. (IBRX)	$113.3M	—	—	$10.60B
Century Therapeutics, Inc. (IPSC)	$109.2M	-8.8%	—	$271.6M
Sutro Biopharma, Inc. (STRO)	$102.5M	—	—	$181.4M
4D Molecular Therapeutics, Inc. (FDMT)	$85.2M	—	—	$682.8M
MeiraGTx Holdings plc (MGTX)	$81.4M	—	—	$949.9M
Autolus Therapeutics plc (AUTL)	$75.4M	—	—	$449.8M
Recursion Pharmaceuticals, Inc. (RXRX)	$74.7M	—	—	$2.06B
Compugen Ltd. (CGEN)	$72.8M	48.6%	5.3×	$189.4M
Black Diamond Therapeutics, Inc. (BDTX)	$70.0M	32.0%	—	$97.4M
Vir Biotechnology, Inc. (VIR)	$68.6M	—	—	$1.69B
Champions Oncology, Inc. (CSBR)	$59.4M	-2.0%	—	$66.9M
Invivyd, Inc. (IVVD)	$53.4M	-98.2%	—	$197.1M
Protalix BioTherapeutics, Inc. (PLX)	$52.7M	-12.5%	—	$211.1M
Fennec Pharmaceuticals Inc. (FENC)	$44.6M	-21.8%	—	$362.9M
Coherus Oncology, Inc. (CHRS)	$42.2M	—	—	$162.2M
Editas Medicine, Inc. (EDIT)	$40.5M	—	—	$374.7M
Voyager Therapeutics, Inc. (VYGR)	$40.4M	—	—	$123.9M
Sangamo Therapeutics, Inc. (SGMOQ)	$39.6M	—	—	$45.6M
Kymera Therapeutics, Inc. (KYMR)	$39.2M	—	—	$8.90B
C4 Therapeutics, Inc. (CCCC)	$35.9M	—	—	$321.1M
X4 Pharmaceuticals, Inc (XFOR)	$35.1M	—	—	$288.5M
Precision Biosciences Inc. (DTIL)	$34.3M	—	—	$170.3M
Scilex Holding Co (SCLX)	$30.3M	—	—	$19.9M
Metagenomi Therapeutics, Inc. (MGX)	$25.2M	—	—	$29.6M
Alector, Inc. (ALEC)	$21.0M	—	—	$205.4M
LENZ Therapeutics, Inc. (LENZ)	$19.1M	—	—	$102.7M
Pelthos Therapeutics Inc. (PTHS)	$16.8M	—	—	$77.1M
Relay Therapeutics, Inc. (RLAY)	$15.4M	—	—	$3.92B
Lineage Cell Therapeutics, Inc. (LCTX)	$13.6M	—	—	$247.4M
Elutia Inc. (ELUT)	$12.3M	—	0.9×	$34.2M
Caribou Biosciences, Inc. (CRBU)	$11.2M	—	—	$49.3M
TScan Therapeutics, Inc. (TCRX)	$10.3M	—	—	$14.7M
Alpha Cognition Inc. (ACOG)	$10.2M	—	—	$178.4M
Taysha Gene Therapies, Inc. (TSHA)	$9.8M	—	—	$1.46B
Curis Inc. (CRIS)	$9.4M	-80.3%	—	$1.2M
Fate Therapeutics Inc. (FATE)	$6.6M	—	—	$230.7M
DBV Technologies S.A. (DBVT)	$5.6M	—	—	$568.8M
CRISPR Therapeutics AG (CRSP)	$3.5M	—	—	$4.98B
Surrozen, Inc. (SRZN)	$3.5M	—	—	$349.0M
Artiva Biotherapeutics, Inc. (ARTV)	$0	—	—	$331.0M
Denali Therapeutics Inc. (DNLI)	$0	—	—	$3.03B
Revolution Medicines, Inc. (RVMD)	$0	—	—	$38.14B
Maze Therapeutics, Inc. (MAZE)	—	—	—	$1.53B

Popular comparisons

AMGN vs GILD AMGN vs MRNA GILD vs MRNA AMGN vs RVMD AMGN vs BIIB AMGN vs EXEL AMGN vs NBIX AMGN vs TECH All comparisons →

Other industries

Semiconductor Stocks Software Stocks Pharmaceutical Stocks REIT Stocks Bank Stocks Oil and Gas Stocks Insurance Stocks Medical Device Stocks Restaurant Stocks

Screen biotech stocks on fundamentals

Filter this industry by margin, growth and valuation, compare any two companies side by side, and ask their filings a question with cited answers.

Start free

Industry grouping is derived from each company’s SEC-assigned SIC code, which is self-reported and coarse: a company is placed by its primary declared line of business. Financial statements come from SEC EDGAR; valuation figures use market data. Informational only. Not investment advice.